Superficial Bladder Cancer Therapy
Bladder cancer treatment remains a challenge despite significant improvements in preventing disease progression and improving survival. Intravesical therapy has been used in the management of superficial transitional cell carcinoma (TCC) of the urinary bladder (i.e. Ta, T1, and carcinoma in situ) wi...
Saved in:
| Main Authors: | Emmanuel Schenkman, Donald L. Lamm |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2004-01-01
|
| Series: | The Scientific World Journal |
| Online Access: | http://dx.doi.org/10.1100/tsw.2004.81 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Superficial Bladder Cancer
by: Ziya Kirkali
Published: (2006-01-01) -
Toxicity of intravesical gemcitabine in superficial bladder cancer treatment
by: R. Gavira Moreno, et al.
Published: (2014-05-01) -
Best Approach for Low-Risk Superficial Bladder Cancer
by: Eduardo Solsona
Published: (2006-01-01) -
The Role of the Surgeon and Transurethral Resection in the Treatment of Superficial Bladder Cancer
by: Alan M. Nieder, et al.
Published: (2006-01-01) -
Bladder Preservation With Transurethral Tumor Resection and Intravesical BCG Instillation in Superficial Muscle-Invasive Bladder Cancer: A 10-Year Follow-up
by: Dong Gyun Kim, et al.
Published: (2023-03-01)